In pancreatic adenocarcinoma, knockdown of RUNX2 expression by specific shRNA caused a decrease in ASPC-1 cell migration, accompanied by phosphorylation activation of the MAPK and PI3K/AKT axes [16]. Here, RUNX2 is linked to pancreatic adenocarcinoma.